One factor that perhaps doesn't matter with starts ups or biotechs but it’s worth mentioning is the “September Rally” many investors are on summer vacation and usually return to the stock market late August-early September.
If I recall correctly, trials are “scheduled” to begin in the 4th qtr. (given FDA Approval of course) could it be that Koos also realizes the importance of the timing in the stock market and set up the schedule for this purpose. I don’t know, but I won’t be surprised if that is the case.
Trying to put the pieces together here:
Product: There is no question BMSN has the product that would change the science world
Chart Technical: its uptrend continues
Timing: I think this is one of the missing components (explained above)
What do you think? I’m open for suggestions trying to solve this puzzle.
(0)
(0)
